CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 98 enrolled
Drug / intervention
Effects of doxazosin on morning surge in diabetic patientsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00295555
NCT00295555Phase 4Completed

Effects of Doxazosin on Ambulatory Blood Pressure and Sympathetic Nervous Activity in Hypertensive Patients With Diabetic Nephropathy

Yokohama City University Medical Center·interventional·Posted Feb 23, 2006·Updated May 10, 2007

In Brief

A Phase 4 clinical trial evaluating Effects of doxazosin on morning surge in diabetic patients for Diabetes Mellitus and 2 related conditions. Completed, enrolled 98 participants across 1 site.

Detailed Summary

Few studies have reported the effect of alpha1-adrenergic antagonists on 24-h blood pressure and regulation of sympathetic nervous activity in hypertensive patients with diabetic nephropathy. Using ambulatory blood pressure monitoring devices equipped with spectral analysis of heart rate variability, we assess the effects of doxazosin on blood pressure in diabetic nephropathy patients and compare the results with those in patients with essential hypertension, patients with diabetes mellitus and patients with chronic nephropathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesJapan
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 23, 2006
Enrollment StartJan 1, 2004
Study CompletionApr 1, 2007
TodayJul 2, 2026
Posted 20.4 years ago

Interventions

Effects of doxazosin on morning surge in diabetic patientsdrug